Site-Specific 68 Ga Radiolabeling of Trastuzumab Fab via Methionine for ImmunoPET Imaging
Bioconjugate Chemistry · 2023
DOI: 10.1021/acs.bioconjchem.3c00344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2023. Verfasst von Thomas T C Yue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, White City Campus, Wood Lane, London W120BZ, U.K. Hauptthemen laut MEDLINE: Neoplasms, Immunoconjugates. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Cancer Research UK.
Abstract (Originalsprache)
Bioconjugates of antibodies and their derivatives radiolabeled with β+-emitting radionuclides can be utilized for diagnostic PET imaging. Site-specific attachment of radioactive cargo to antibody delivery vectors provides homogeneous, well-defined immunoconjugates. Recent studies have demonstrated the utility of oxaziridine chemistry for site-specific labeling of methionine residues. Herein, we applied this approach to site-specifically radiolabel trastuzumab-derived Fab immunoconjugates with 68Ga, which can be used for in vivo PET imaging of HER2-positive breast cancer tumors. Initially, a reactive azide was introduced to a single solvent-accessible methionine residue in both the wild-type Fab and an engineered derivative containing methionine residue M74, utilizing the principles of oxaziridine chemistry. Subsequently, these conjugates were functionalized with a modified DFO chelator incorporating dibenzocyclooctyne. The resulting DFO-WT and DFO-M74 conjugates were radiolabeled with generator-produced [68Ga]Ga3+, to yield the novel PET radiotracers, [68Ga]Ga-DFO-WT and [68Ga]Ga-DFO-M74. In vitro and in vivo studies demonstrated that [68Ga]Ga-DFO-M74 exhibited a higher affinity for HER2 receptors. Biodistribution studies in mice bearing orthotopic HER2-positive breast tumors revealed a higher uptake of [68Ga]Ga-DFO-M74 in the tumor tissue, accompanied by rapid renal clearance, enabling clear delineation of tumors using PET imaging. Conversely, [68Ga]Ga-DFO-WT exhibited lower uptake and inferior image contrast compared to [68Ga]Ga-DFO-M74. Overall, the results demonstrate that the highly facile methionine-oxaziridine modification approach can be simply applied to the synthesis of stable and site-specifically modified radiolabeled antibody-chelator conjugates with favorable pharmacokinetics for PET imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, White City Campus, Wood Lane, London W120BZ, U.K.
- School of Biomedical Engineering and Imaging Sciences, King's College London, Fourth Floor Lambeth Wing, St. Thomas' Hospital, London SE17EH, U.K.
- Department of Chemistry and Institute of Chemical Biology, Molecular Sciences Research Hub, Imperial College London, White City Campus, Wood Lane, London W120BZ, U.K.
ORCID-Profile: Ying Ge, Francesco A Aprile, Michelle T Ma, Truc T Pham, Nicholas J Long
Förderung
- Wellcome Trust
- Medical Research Council
- Cancer Research UK
- EPSRC
Zitieren
APA
Yue, T. T. C., Ge, Y., Aprile, F. A., Ma, M. T., Pham, T. T., & Long, N. J. (2023). Site-Specific 68 Ga Radiolabeling of Trastuzumab Fab via Methionine for ImmunoPET Imaging. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.3c00344
Vancouver
Yue TTC, Ge Y, Aprile FA, Ma MT, Pham TT, Long NJ. Site-Specific 68 Ga Radiolabeling of Trastuzumab Fab via Methionine for ImmunoPET Imaging. Bioconjugate Chemistry. 2023. doi:10.1021/acs.bioconjchem.3c00344
BibTeX
@article{Yue2023,
author = {Yue, Thomas T C and Ge, Ying and Aprile, Francesco A and Ma, Michelle T and Pham, Truc T and Long, Nicholas J},
title = {Site-Specific 68 Ga Radiolabeling of Trastuzumab Fab via Methionine for ImmunoPET Imaging},
journal = {Bioconjugate Chemistry},
year = {2023},
doi = {10.1021/acs.bioconjchem.3c00344}
}
EUVIMED